Health

Painkiller study looks at risk management

NEWS IN BRIEF — Posted Jan. 23, 2006

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

Genetic makeup contributed about 30% to the variability with which individuals responded to the painkillers Vioxx and Celebrex, according to a recent study. Both of the COX-2 inhibitors now have been withdrawn from the market because of the risk they carried for heart attacks and stroke. The analysis of how people vary in their response to the drugs was published in the January issue of Gastroenterology.

Researchers at the University of Pennsylvania examined the variability, both within and between subjects, in response to rofecoxib, or Vioxx, and celecoxib, or Celebrex, in a randomized, double-blind, placebo-controlled trial.

Fifty healthy volunteers between ages 21 and 43 received a single dose of placebo, celecoxib and rofecoxib in random order. This was done to allow researchers a direct comparison of the responses to the drugs within the same subjects.

Approximately 30% of the variability found in patients was attributable to differences between individuals, suggesting the contribution of genetics to a variety of biomarkers of drug response. The study also illustrated that even healthy individuals without a recognized risk of disease respond quite differently to the drugs.

The authors said they hoped that their work would provide an impetus for the development of a science-based approach to risk management. Exploitation of variability in response can lead to tests that identify patients most likely to benefit or have harmful side effects caused by these drugs, they said.

Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/01/23/hlbf0123.htm.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn